Showing 6531-6540 of 21451 results for "".
- Emerging Pediatric Challenges: Tackling Pulmonary Embolism with Updated Protocolshttps://reachmd.com/news/emerging-pediatric-challenges-tackling-pulmonary-embolism-with-updated-protocols/2474773/Pulmonary embolism is increasingly recognized as a concerning condition in pediatric patients, demanding new diagnostic and treatment approaches. Observations of pediatric thromboembolism are reshaping clinical practices. Recent data r
- Pancreatic Cancer Management: Standard-Adherent Surgery and Guideline-Based Therapyhttps://reachmd.com/news/pancreatic-cancer-management-standard-adherent-surgery-and-guideline-based-therapy/2474780/Integrating evidence-based therapies with standardized surgical protocols is increasingly recognized as essential in improving outcomes for patients with pancreatic cancer. Recent studies have demonstrated that strict adherence to structured surgical procedures can
- Abbreviated Breast MRI: Enhancing Cancer Detection in Dense Breastshttps://reachmd.com/news/abbreviated-breast-mri-enhancing-cancer-detection-in-dense-breasts/2474748/Advancements in breast imaging have introduced abbreviated breast MRI exams, maintaining high diagnostic precision while significantly reducing scan times. This innovation is particularly meaningful for elevating detection rates in women with extremely dense breast
- Combination Therapy and Outcomes in Childhood B-Cell Acute Lymphoblastic Leukemiahttps://reachmd.com/news/combination-therapy-and-outcomes-in-childhood-b-cell-acute-lymphoblastic-leukemia/2474731/Recent innovations in pediatric oncology reveal a dual-drug therapy developed by Cambridge researchers, representing a significant leap forward by reducing chemotherapy reliance while improving outcomes, notably in older pediatric B-cell acute lymphoblastic leukemia patient
- The Role of PAX3 in Melanoma Progressionhttps://reachmd.com/news/the-role-of-pax3-in-melanoma-progression/2474728/Melanoma, a highly lethal skin cancer, is governed by intricate molecular pathways. Recent insights highlight the pivotal role of the PAX3 protein in accelerating cell growth, migration, and survival while suppressing terminal differentiation, thereby
- Genetic Modulation of Cortical Development: The Role of HARE5 Enhancerhttps://reachmd.com/news/genetic-modulation-of-cortical-development-the-role-of-hare5-enhancer/2474727/The identification of the HARE5 enhancer is a pivotal leap forward in comprehending brain development. This human-specific genetic element significantly impacts neural progenitor proliferation, contributing to cortical expansion. This discovery not only elucidates
- Wearable Technology: Revolutionizing Obstructive Sleep Apnea Managementhttps://reachmd.com/news/wearable-technology-revolutionizing-obstructive-sleep-apnea-management/2474722/Obstructive sleep apnea (OSA) affects an estimated 9% to 38% of adults, with prevalence increasing with age and higher in men. However, in-laboratory polysomnography, the standard diagno
- Home-Based Digital Counseling and Colorectal Cancer Screeninghttps://reachmd.com/news/home-based-digital-counseling-and-colorectal-cancer-screening/2474739/Recent research illustrates that home-based digital counselling effectively reduces the frequency of outpatient visits while sustaining robust levels of patient readiness. Non-inferiority studies validate that these digital methods parallel traditional face-to-face
- Magnetically Controlled Growth Rods: Advancements and Considerations in Pediatric Scoliosishttps://reachmd.com/news/magnetically-controlled-growth-rods-advancements-and-considerations-in-pediatric-scoliosis/2474721/Magnetically controlled growth rods are reshaping pediatric scoliosis surgery by enhancing thoracic height and improving correction outcomes without frequent invasive interve
- Triple-Combo Gel for Acne: Evaluating Long-Term Efficacy and Safetyhttps://reachmd.com/news/triple-combo-gel-for-acne-evaluating-long-term-efficacy-and-safety/2474740/Recent clinical evidence confirms the efficacy of a triple‐combo gel incorporating clindamycin phosphate, adapalene, and benzoyl peroxide in managing moderate acne. A 24‐week study observed a 68% treatment success rate, with an 89% reduction in inflammatory lesions